Education
About Us
Working with TipRanks
Follow Us
Steris plc (STE)
NYSE:STE
STE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$197.82 - $248.24
Previous CloseN/A
Volume53.54K
Average Volume (3M)534.08K
Market Cap
$21.66B
Enterprise Value$22.52B
Total Cash (Recent Filing)$155.18M
Total Debt (Recent Filing)$2.32B
Price to Earnings (P/E)46.7
Beta0.44
Next Earnings
May 20, 2025EPS Estimate
2.6Last Dividend Ex-Date
Feb 20, 2025Dividend Yield1.01%
Share Statistics
EPS (TTM)4.71
Shares Outstanding98,250,786
10 Day Avg. Volume613,450
30 Day Avg. Volume534,084
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.25
Price to Cash Flow (P/CF)16.30
P/FCF Ratio16.30
Enterprise Value/Market Cap1.04
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.15
Enterprise Value/Ebitda18.35
Forecast
1Y Price Target
$265.00Price Target Upside18.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Steris News
PremiumCompany Announcements
STERIS Reports Strong Q3 Results with Revenue Growth
PremiumCompany Announcements
STERIS Earnings Call Highlights Mixed Sentiment and Growth
---
Bulls Say, Bears Say
Bulls Say
Analyst RatingThe Market Outperform rating is reiterated for STERIS, reflecting confidence in the company's future performance.
Shareholder ValueCompletion of $100 million in share repurchases and debt reduction efforts demonstrate a commitment to enhancing shareholder value and improving financial stability.
Bears Say
Backlog DelaysThe orders are unlikely to be shipped until FY26, affecting Healthcare and Life Sciences backlogs.
GuidanceManagement lowered their revenue and EPS guidance modestly given increased currency headwinds and delayed Healthcare capital equipment orders.
Legal ExpensesOperating margin was down 10 bps Y/Y and below consensus as STE faced increased legal expenses related to its ongoing ethylene oxide (EO) trial.
---
Ownership Overview
0.31% Insiders
27.95% Mutual Funds
27.51% Other Institutional Investors
18.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STE FAQ
What was Steris plc’s price range in the past 12 months?
Steris plc lowest stock price was $197.82 and its highest was $248.24 in the past 12 months.
What is Steris plc’s market cap?
Steris plc’s market cap is $21.66B.
When is Steris plc’s upcoming earnings report date?
Steris plc’s upcoming earnings report date is May 20, 2025 which is in 56 days.
How were Steris plc’s earnings last quarter?
Steris plc released its earnings results on Feb 05, 2025. The company reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.321 by -$0.001.
Is Steris plc overvalued?
According to Wall Street analysts Steris plc’s price is currently Undervalued.
Does Steris plc pay dividends?
Steris plc pays a Quarterly dividend of $2.226 which represents an annual dividend yield of 1.01%. See more information on Steris plc dividends here
What is Steris plc’s EPS estimate?
Steris plc’s EPS estimate is 2.6.
How many shares outstanding does Steris plc have?
Steris plc has 98,250,786 shares outstanding.
What happened to Steris plc’s price movement after its last earnings report?
Steris plc reported an EPS of $2.32 in its last earnings report, missing expectations of $2.321. Following the earnings report the stock price went up 2.088%.
Which hedge fund is a major shareholder of Steris plc?
Currently, no hedge funds are holding shares in STE
---
Steris Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$265.00 (18.83% Upside)
$265.00 (18.83% Upside)
Blogger Sentiment
Bullish
STE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 369.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $365.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.64%
12-Months-Change
Fundamentals
Return on Equity
9.61%
Trailing 12-Months
Asset Growth
-12.48%
Trailing 12-Months
Company Description
Steris plc
Steris (STE) is a leading provider of infection prevention and other procedural products and services, primarily catering to the healthcare, pharmaceutical, and research industries. The company specializes in sterilization and surgical products, infection prevention solutions, and laboratory equipment. It operates across several sectors, including healthcare, life sciences, and applied sterilization technologies, offering a range of products such as sterilizers, surgical tables, and endoscopy processing equipment.
---
STE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view, with strong revenue growth and improved gross margins balanced by challenges in EBIT margin and segment-specific revenue declines, particularly in healthcare capital equipment and life sciences. Positive trends in free cash flow and the AST segment's growth were countered by ongoing litigation expenses and unfavorable currency impacts.Read More>---
STE Revenue Breakdown
73.00% U.S.
25.39% Other locations
1.61% Ireland
---
STE Stock 12 Month Forecast
Average Price Target
$265.00
▲(18.83% Upside)
Technical Analysis
Becton Dickinson
―
DENTSPLY SIRONA
―
Intuitive Surgical
―
Stryker
―
Zimmer Biomet Holdings
―
Best Analysts Covering STE
1 Year
1 Year Success Rate
22/31 ratings generated profit
1 Year Average Return
+7.45%
reiterated a buy rating 2 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 70.97% of your transactions generating a profit, with an average return of +7.45% per trade.
---